This multi-center approach, combined with a large sample size investigation, permitted the assessment of the reproducibility of TRPM3 function as a robust biomarker for ME/CFS. The gene discussed is TRPM3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.